Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 1/20 | 0.42 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.37 |
| ▸ | UBE2M | P61081 | 1/20 | 0.36 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11031885 | 0.82 | FUCA1 (0.51) | RORCFUCA1S1PR5S1PR1DRD2 | |
| SCHEMBL583636 | 0.82 | FUCA1 (0.51) | RORCFUCA1S1PR5S1PR1DRD2 | |
| SCHEMBL1505186 | 0.82 | FUCA1 (0.51) | RORCFUCA1S1PR5S1PR1DRD2 | |
| SCHEMBL29961188 | 0.80 | FUCA1 (0.42) | RORCFUCA1CHRM2CHRM3S1PR5 | |
| SCHEMBL29960624 | 0.80 | FUCA1 (0.42) | RORCFUCA1CHRM2CHRM3S1PR5 | |
| SCHEMBL29960801 | 0.77 | DRD2 (0.43) | RORCFUCA1S1PR5S1PR1DRD2 | |
| SCHEMBL24535980 | 0.76 | FUCA1 (0.51) | RORCFUCA1S1PR5S1PR1DRD2 | |
| SCHEMBL12430143 | 0.73 | DRD2 (0.46) | DRD2ALDH1A1SIGMAR1 | |
| SCHEMBL12430140 | 0.71 | DRD2 (0.46) | DRD2ALDH1A1SIGMAR1 | |
| SCHEMBL1803424 | 0.71 | DRD2 (0.40) | FUCA1S1PR5S1PR1DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022204150-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | BLUE OAK PHARMACEUTICALS, INC. (US) | 2022-09-29 | — | — | WO | disclosed |